in the present study , we demonstrate that broadly cytotoxic lymphocytes , generated by in vitro culture with human recombinant interleukin 2 , and used in conjunction with the chemotherapeutic drug doxorubicin hydrochloride , are effective in treating invasive and metastatic renal cell cancer .
C0086418
human
C0021756
recombinant interleukin 2